Delta-9-tetrahydrocannabinol (THC) is an effective antiemetic as compared with placebos in patients receiving chemotherapy for cancer. In this study we compared THC with prochlorperazine (compazine) in a randomized, double-blind, crossover trial with patients who had failed to benefit from standard antiemetic therapy. Regardless of the emetic activity of the chemotherapeutic agents, there were more complete responses to THC courses (in 36 of 79 courses) than to prochlorperazine (in 16 of 78 courses). Of 25 patients who were treated with both drugs and who expressed a preference, 20 preferred THC (P = 0.005). Among patients under 20 years of age there was a higher proportion of complete responses to THC courses (15 of 20) than among older patients (21 of 59 courses; P = 0.004). Increased food intake occurred more frequently with THC (P = 0.008) and was associated with the presence of a "high." Of 36 THC courses resulting in complete antiemetic responses, 32 were associated with a high. We conclude that THC is an effective antiemetic in many patients who receive chemotherapy for cancer and for whom other antiemetics are ineffective. (N Engl J Med 302:135--138, 1980).
This article has been cited by other articles:
Tramer, M. R, Carroll, D., Campbell, F. A, Reynolds, D J. M, Moore, R A., McQuay, H. J
(2001). Cannabinoids for control of chemotherapy induced nausea and vomiting: quantitative systematic review. BMJ
323: 16-16
[Abstract][Full Text]
Gralla, R. J., Osoba, D., Kris, M. G., Kirkbride, P., Hesketh, P. J., Chinnery, L. W., Clark-Snow, R., Gill, D. P., Groshen, S., Grunberg, S., Koeller, J. M., Morrow, G. R., Perez, E. A., Silber, J. H., Pfister, D. G.
(1999). Recommendations for the Use of Antiemetics: Evidence-Based, Clinical Practice Guidelines. JCO
17: 2971-2971
[Full Text]
Grunberg, S. M., Hesketh, P. J.
(1993). Control of Chemotherapy-Induced Emesis. NEJM
329: 1790-1796
[Full Text]
CASSILETH, P. A., LUSK, E. J., TORRI, S., GERSON, S. L.
(1984). Antiemetic Efficacy of High-Dose Dexamethasone in Induction Therapy in Acute Nonlymphocytic Leukemia. ANN INTERN MED
100: 701-702
[Abstract]
CAREY, M. P., BURISH, T. G., BRENNER, D. E.
(1983). Delta-9-Tetrahydrocannabinol in Cancer Chemotherapy: Research Problems and Issues. ANN INTERN MED
99: 106-114
[Abstract]
Cassileth, P. A., Lusk, E. J., Torri, S., DiNubile, N., Gerson, S. L.
(1983). Antiemetic Efficacy of Dexamethasone Therapy in Patients Receiving Cancer Chemotherapy. Arch Intern Med
143: 1347-1349
[Abstract]
Strum, S. B., McDermed, J. E., Opfell, R. W., Riech, L. P.
(1982). Intravenous Metoclopramide: An Effective Antiemetic in Cancer Chemotherapy. JAMA
247: 2683-2686
[Abstract]
Council on Scientific Affairs,
(1981). Marijuana: Its Health Hazards and Therapeutic Potentials. JAMA
246: 1823-1827
[Abstract]
SEIGEL, L. J., LONGO, D. L.
(1981). The Control of Chemotherapy-Induced Emesis. ANN INTERN MED
95: 352-359
[Abstract]
Frytak, S., Moertel, C. G.
(1981). Management of Nausea and Vomiting in the Cancer Patient. JAMA
245: 393-396
[Abstract]
Previous
